BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 20656230)

  • 1. Percutaneous ablation of hepatocellular carcinoma: current status.
    McWilliams JP; Yamamoto S; Raman SS; Loh CT; Lee EW; Liu DM; Kee ST
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S204-13. PubMed ID: 20656230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
    Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
    J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver tumor ablation: percutaneous and open approaches.
    Padma S; Martinie JB; Iannitti DA
    J Surg Oncol; 2009 Dec; 100(8):619-34. PubMed ID: 20017157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ablation of skeletal metastases: current status.
    Kurup AN; Callstrom MR
    J Vasc Interv Radiol; 2010 Aug; 21(8 Suppl):S242-50. PubMed ID: 20656234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
    Ohki T; Tateishi R; Shiina S; Sato T; Masuzaki R; Yoshida H; Kanai F; Obi S; Yoshida H; Omata M
    Liver Int; 2007 Apr; 27(3):360-7. PubMed ID: 17355458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous ablation for small hepatocellular carcinoma.
    Yin XY; Lu MD
    Expert Rev Gastroenterol Hepatol; 2009 Apr; 3(2):121-30. PubMed ID: 19351283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local ablation therapy for hepatocellular carcinoma. From ethanol injection to radiofrequency ablation.
    Shiina S; Tateishi R; Yoshida H; Kanai F; Omata M
    Saudi Med J; 2007 Jun; 28(6):831-7. PubMed ID: 17530094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
    Izumi N
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-Surgical tumor ablation of hepatocellular carcinoma].
    Koike Y; Omata M
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1276-9. PubMed ID: 14518406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microwave ablation of hepatocellular carcinoma.
    Liang P; Wang Y
    Oncology; 2007; 72 Suppl 1():124-31. PubMed ID: 18087193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Less invasive medical therapy for hepatocellular carcinoma].
    Ikeda K
    Gan To Kagaku Ryoho; 2001 Aug; 28(8):1083-9. PubMed ID: 11525022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
    Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
    Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
    Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
    Mahnken AH; Bruners P; Günther RW
    Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technologies for ablation of hepatocellular carcinoma.
    Callstrom MR; Charboneau JW
    Gastroenterology; 2008 Jun; 134(7):1831-5. PubMed ID: 18486619
    [No Abstract]   [Full Text] [Related]  

  • 19. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A promising new treatment strategy for advanced hepatocellular carcinoma--"multi-ablation therapy" consisting of radio-frequency ablation (RFA), microwave coagulation therapy (MCT) and ethanol injection therapy (EIT)].
    Beppu T; Ishiko T; Doi K; Matsuda T; Maeda T; Ishihara K; Ogata K; Ogawa M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1583-6. PubMed ID: 11707985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.